Agios Pharmaceuticals Inc.
|Number of Estimates|
Agios Pharmaceuticals Inc is a biopharmaceutical company which focuses on developing treatments geared towards cancer and rare genetic disorders of metabolism. It also emphasizes on developing potentially transformative small-molecule medicines.
Market Cap: 4.5 Billion
Primary Exchange: Nasdaq Global Select
Shares Outstanding: 55.7 Million
Float: 55 Million
Dividend: 0.0 (0.0%)
Short Interest (Jan 12, 2018): 6.72 Million
Longest drawdown: 1200 trading days
From: 2015-01-14 To: 2019-10-17
Key events next week - healthcare
via: SeekingAlpha at 2019-06-13 03:28:10:000
Noteworthy events during the week of June 16 - 22 for healthcare investors. More news on: ProMIS Neurosciences, Inc., Merck & Co., Inc., IQVIA Holdings Inc., Healthcare stocks news, , Read more … read more...
|Ex-Date||Payment Date||Record Date||Declared Date||Amount||Flag||Dividend Type||Qualified||Indicated|
|Ex-Date||Declared Date||Record Date||Payment Date||Ratio||To Factor||For Factor|